A changing market demands new approaches to drug development
from By Dr. Paul Nelles
Biopharmaceutical companies are under enormous pressure to compete in new ways if they are going to survive. Shrinking product pipelines of many pharma companies; increasing costs associated with drug development; a blockbuster model that is giving way to more advanced treatments; and growing regulatory oversight are contributors to this added pressure. The drug development model of today is far more sophisticated than the model of just a few years ago. This is mainly due to the greater degree of complexity of new compounds being developed.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063